More Than Half Of Americans Want New COVID-19 Booster, But Ron DeSantis Will Fight Virus With His Charisma Alone
Portfolio Pulse from Chris Katje
COVID-19 vaccine boosters from Pfizer Inc (PFE), Moderna Inc (MRNA), and BioNTech SE - ADR (BNTX) have been approved by the U.S. FDA. Novavax Inc (NVAX) has a vaccine booster awaiting approval. A new survey shows that over half of U.S. registered voters plan to get a COVID-19 booster vaccine this year. The approval of these boosters comes as hospitalizations related to COVID-19 have increased in recent months.
September 15, 2023 | 8:19 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
BioNTech's COVID-19 booster has been approved by the FDA, which could increase demand for the company's vaccine.
The FDA's approval of BioNTech's COVID-19 booster could lead to increased demand for the vaccine, potentially boosting the company's revenues.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Moderna's COVID-19 booster has been approved by the FDA, which could increase demand for the company's vaccine.
The FDA's approval of Moderna's COVID-19 booster could lead to increased demand for the vaccine, potentially boosting the company's revenues.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Pfizer's COVID-19 booster has been approved by the FDA, which could increase demand for the company's vaccine.
The FDA's approval of Pfizer's COVID-19 booster could lead to increased demand for the vaccine, potentially boosting the company's revenues.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEUTRAL IMPACT
Novavax's COVID-19 booster is awaiting FDA approval. If approved, this could increase demand for the company's vaccine.
Novavax's COVID-19 booster is still awaiting FDA approval. If approved, this could lead to increased demand for the vaccine, potentially boosting the company's revenues.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100